1. 10-hydroxycamptothecine
1. 19685-09-7
2. (s)-10-hydroxycamptothecin
3. Hydroxycamptothecin
4. 10-hydroxycamptothecine
5. 10-hydroxy Camptothecin
6. Hydroxycamptothecine
7. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
8. Camptothecin, Hydroxy-
9. 10-hcpt
10. 10-hydroxy-camptothecin
11. (4s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
12. Camptothecine, 10-hydroxy-
13. Irinotecan Related Compound A
14. Nsc107124
15. Nsc-107124
16. Chembl273862
17. Chebi:81395
18. 9z01632krv
19. Mfcd02093100
20. (+)-(s)-10-hydroxycamptothecin
21. (s)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h)-dione
22. Camptothecin, 10-hydroxy-
23. (20s)-4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
24. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione ((s)-10-hydroxycamptothecin)
25. Nsc 107124
26. (s)-10-hydroxycamptothecin Hydrate
27. Unii-9z01632krv
28. (20s)-10-hydroxycamptothecin
29. Camptothecin, 10-hydroxy
30. 10-hydroxy-cpt
31. Spectrum_001639
32. Specplus_000763
33. Spectrum2_001660
34. Spectrum3_001621
35. Spectrum4_001815
36. Spectrum5_000549
37. Ethyl(dihydroxy)[?]dione
38. Schembl25875
39. Bspbio_003281
40. Kbiogr_002454
41. Kbioss_002119
42. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 4-ethyl-4,9-dihydroxy-, Hydrate, (s)-
43. Divk1c_006859
44. Spectrum1504123
45. Spbio_001819
46. Kbio1_001803
47. Kbio2_002119
48. Kbio2_004687
49. Kbio2_007255
50. Kbio3_002501
51. Dtxsid00941444
52. Ex-a988
53. Bcp01385
54. Hy-n0095
55. Zinc3979155
56. (+)-10-hydroxycamptothecin
57. Bdbm50008922
58. Ccg-38770
59. S2423
60. S3898
61. Akos015919293
62. Ac-5502
63. Bcp9000058
64. Cs-5193
65. Db12385
66. 10-hydroxycamptothecin [who-dd]
67. Ncgc00095986-01
68. Ncgc00095986-02
69. Ncgc00095986-03
70. Ncgc00095986-04
71. Ncgc00178165-01
72. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione-,4-ethyl-4,9-dihydroxy-, (s)-
73. Ac-13221
74. As-13196
75. Nci60_000173
76. Sy010687
77. H1463
78. N2591
79. 85h097
80. A25382
81. C17939
82. Irinotecan Related Compound A [usp-rs]
83. Sr-05000002620
84. Q-100241
85. Sr-05000002620-1
86. Brd-k63784565-001-02-1
87. Brd-k63784565-001-03-9
88. Q27155328
89. 4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
90. (19s)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
91. (alphas)-alpha,2-dihydroxy-alpha-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinoline-7-acetic Acid 7,8-lactone
92. (s)-10-hydroxycamptothecin;-;(+/-)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
93. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3 Inverted Exclamation Mark ,4 Inverted Exclamation Mark :6,7]indolizino[1,2-b]quinoline-3,14-(4h,12h)-dione
94. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4h,12h)-dione
95. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 4-ethyl-4,9-dihydroxy-, (4s)-
96. 1h-pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione-,4-ethyl-4,9-dihydroxy-, (s)-
97. 4-ethyl-4,10-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
98. 4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (10-hydroxycamptothecin)
1. Hcpt
2. Hydroxycamptothecin
3. Hydroxycamptothecine
| Molecular Weight | 364.4 g/mol |
|---|---|
| Molecular Formula | C20H16N2O5 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 364.10592162 g/mol |
| Monoisotopic Mass | 364.10592162 g/mol |
| Topological Polar Surface Area | 100 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 774 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
BUILDING BLOCK
SUPPLIERS
CAS Number : 19685-09-7
End Use API :
End Use API : Topotecan Hydrochloride
About the Company : Chengdu Chen Green Biotechnology (Chen Green) is a company specializing in plant extracts, pharmaceutical raw materials, food additives and dietary supplements manufacturers and wholesa...
CAS Number : 19685-09-7
End Use API :
End Use API : Irinotecan Hydrochloride
About the Company : Chengdu Yazhong Bio-pharmaceutical Co., Ltd., founded in 2002, is a leading company with plant extracts, APIs and medical intermediates. Our company is equipped with GMP approved manufa...
CAS Number : 19685-09-7
End Use API :
End Use API : Topotecan Hydrochloride
About the Company : The technology of production of artemisinin and its derivatives is based on the use of cultivation of annual wormwood cells and extraction of artemisinin and artemisinic acid. Quality c...
CAS Number : 19685-09-7
End Use API :
End Use API : Topotecan Hydrochloride
About the Company : Founded in 1980, Sichuan Xieli Pharmaceutical Co., Ltd. operates with the guiding principle of "collaborating to build a healthy enterprise." The company specializes in the cultivation ...
END USE APIs
RELATED INTERMEDIATES
